MENU
EOLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Evolus (EOLS) Ownership - Who owns Evolus?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
846.82M
P/E Ratio
N/A
Total Cash
62.84M
Projected Growth
N/A
Total Debt
126.55M
Revenue
202.09M
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash/Share
1.02
Total Debt/Equity
N/A
Revenue/Share
3.55 USD as % of share price
Fundamentals
EOLS
Capitalization
847M
P/E Ratio
N/A
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash
62.8M
Total Cash/Share
1.02
Total Debt
127M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.55%
Revenue
202M
ROE
N/A
Book Value
-20.69M
P/B Ratio
80.65
Cash Flow
N/A
Earnings
-1.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
2.33
Current Revenue Per Employee
223439.56
Dividends Per Share - Security
N/A
EBITDA
-41.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.41
Revenue To Assets
-33.62
Shares Held By Institutions
646M
Shares Outstanding - Current
61.5M
Total Liabilities
210M
Total Volume MTD
N/A
Value
-1
Gain YTD
12.821
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of neurotoxins
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com